Format

Send to

Choose Destination
F1000Res. 2018 Feb 28;7:242. doi: 10.12688/f1000research.12249.1. eCollection 2018.

Recent advances in the diagnosis and management of pre-eclampsia.

Author information

1
Women's Health Academic Centre, King's College London, Westminster Bridge Road, London, SE1 7EH, UK.

Abstract

Pre-eclampsia is a leading cause of maternal mortality, responsible annually for over 60,000 maternal deaths around the globe. Pre-eclampsia is a multisystem disease featuring hypertension, proteinuria, and renal, hepatic, and neurological involvement. Diagnosis is often elusive, as clinical presentation is highly variable. Even those with severe disease can remain asymptomatic. Angiogenic factors are emerging as having a role in the diagnosis of pre-eclampsia and in prognostication of established disease. In this article, we summarize new developments and focus on angiogenic biomarkers for prediction of disease onset. We also discuss recent advances in management strategies for patients with hypertensive disorders of pregnancy.

KEYWORDS:

PlGF; angiogenic biomarkers; diagnosis; hypertensive disorders; pre-eclampsia

Conflict of interest statement

No competing interests were disclosed.No competing interests were disclosed.No competing interests were disclosed.

Publication type

Publication type

Supplemental Content

Full text links

Icon for F1000 Research Ltd Icon for PubMed Central
Loading ...
Support Center